Clinical Trial Update: Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical study evaluating SYS6043 for advanced/metastatic solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SYS6043

Snippet

Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. | Conditions: Advanced/Metastatic Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING